全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用：99美元
投递稿件

为什么选择我们？ >>
- 开源期刊
- 同行审议
- 快速出刊
- 终身存储
- 免费检索
- 免费推广
- 更多...
- 搜索引擎

PPAR Research

ISSN Print: 1687-4757

ISSN Online:

主页: http://www.hindawi.com/journals/ppar/

分享:




Go

The Liver X Receptor in Correlation with Other Nuclear Receptors in Spontaneous and Recurrent Abortions

Julia Knabl,Aurelia Pestka,Rebecca Hüttenbrenner,Torsten Pl？sch,Regina Ensenauer,Lena Welbergen,Stefan Hutter,Maria Günthner-Biller,Udo Jeschke

Doxorubicin-Induced Cardiac Toxicity Is Mediated by Lowering of Peroxisome Proliferator-Activated Receptor δ Expression in Rats

Zhih-Cherng Chen,Li-Jen Chen,Juei-Tang Cheng

Inhibitors of Fatty Acid Synthesis Induce PPARα-Regulated Fatty Acid β-Oxidative Genes: Synergistic Roles of L-FABP and Glucose

Huan Huang,Avery L. McIntosh,Gregory G. Martin,Anca D. Petrescu,Kerstin K. Landrock,Danilo Landrock,Ann B. Kier,Friedhelm Schroeder

PPARs and HCV-Related Hepatocarcinoma: A Mitochondrial Point of View

Francesca Agriesti,Tiziana Tataranni,Vitalba Ruggieri,Nazzareno Capitanio,Claudia Piccoli

Regulation of Genes Involved in Carnitine Homeostasis by PPARα across Different Species (Rat, Mouse, Pig, Cattle, Chicken, and Human)

Robert Ringseis,Gaiping Wen,Klaus Eder

PPARs in Regulation of Paraoxonases: Control of Oxidative Stress and Inflammation Pathways

Jordi Camps,Anabel García-Heredia,Anna Rull,Carlos Alonso-Villaverde,Gerard Aragonès,Raúl Beltrán-Debón,Esther Rodríguez-Gallego,Jorge Joven

Effect of Pioglitazone on the Fructose-Induced Abdominal Adipose Tissue Dysfunction

Ana Alzamendi,Andrés Giovambattista,María E. García,Oscar R. Rebolledo,Juan J. Gagliardino,Eduardo Spinedi

Antioxidant Stress and Anti-Inflammation of PPARα on Warm Hepatic Ischemia-Reperfusion Injury

Zhixin Gao,Yuan-Hai Li

Transcriptional Activity of PGC-1 and NT-PGC-1 Is Differentially Regulated by Twist-1 in Brown Fat Metabolism

Hee-Jin Jun,Thomas W. Gettys,Ji Suk Chang

PPAR -Independent Arterial Smooth Muscle Relaxant Effects of PPAR Agonists

Neerupma Silswal,Nikhil K. Parelkar,Michael J. Wacker,Mostafa Badr,Jon Andresen

Anti- and Protumorigenic Effects of PPARγ in Lung Cancer Progression: A Double-Edged Sword

Howard Li,Mary C. M. Weiser-Evans,Raphael Nemenoff

Fenofibrate Inhibited the Differentiation of T Helper 17 Cells In Vitro

Zhou Zhou,Weiliang Sun,Ying Liang,Yanxiang Gao,Wei Kong,Youfei Guan,Juan Feng,Xian Wang

The Current Knowledge of the Role of PPAR in Hepatic Ischemia-Reperfusion Injury

M. Elias-Miró,M. B. Jiménez-Castro,M. Mendes-Braz,A. Casillas-Ramírez,C. Peralta

The Key to Unlocking the Chemotherapeutic Potential of PPARγ Ligands: Having the Right Combination

Graham Skelhorne-Gross,Christopher J. B. Nicol

AS601245, an Anti-Inflammatory JNK Inhibitor, and Clofibrate Have a Synergistic Effect in Inducing Cell Responses and in Affecting the Gene Expression Profile in CaCo-2 Colon Cancer Cells

Angelo Cerbone,Cristina Toaldo,Stefania Pizzimenti,Piergiorgio Pettazzoni,Chiara Dianzani,Rosalba Minelli,Eric Ciamporcero,Guglielmo Roma,Mario Umberto Dianzani,Roberto Canaparo,Carlo Ferretti,Giuseppina Barrera

Pioglitazone Attenuates Vascular Fibrosis in Spontaneously Hypertensive Rats

Dengfeng Gao,Ning Ning,Guanghua Hao,Xiaolin Niu

PPAR Activation Protects against Anti-Thy1 Nephritis by Suppressing Glomerular NF- B Signaling

Koji Hashimoto,Yuji Kamijo,Takero Nakajima,Makoto Harada,Makoto Higuchi,Takashi Ehara,Hidekazu Shigematsu,Toshifumi Aoyama

Protection from Metabolic Dysregulation, Obesity, and Atherosclerosis by Citrus Flavonoids: Activation of Hepatic PGC1α-Mediated Fatty Acid Oxidation

Erin E. Mulvihill,Murray W. Huff

Peroxisome Proliferator Activated Receptor-α Agonist Slows the Progression of Hypertension, Attenuates Plasma Interleukin-6 Levels and Renal Inflammatory Markers in Angiotensin II Infused Mice

Justin L. Wilson,Rong Duan,Ahmed El-Marakby,Abdulmohsin Alhashim,Dexter L. Lee

The Nitrated Fatty Acid 10-Nitro-oleate Diminishes Severity of LPS-Induced Acute Lung Injury in Mice

Aravind T. Reddy,Sowmya P. Lakshmi,Raju C. Reddy

In Vitro and In Vivo Characterizations of Chiglitazar, a Newly Identified PPAR Pan-Agonist

B. K. He,Z. Q. Ning,Z. B. Li,S. Shan,D. S. Pan,B. C. B. Ko,P. P. Li,Z. F. Shen,G. F. Dou,B. L. Zhang,X. P. Lu,Y. Gao

PPARG Epigenetic Deregulation and Its Role in Colorectal Tumorigenesis

Lina Sabatino,Alessandra Fucci,Massimo Pancione,Vittorio Colantuoni

Prenatal Rosiglitazone Administration to Neonatal Rat Pups Does Not Alter the Adult Metabolic Phenotype

Hernan Sierra,Reiko Sakurai,W. N. Paul Lee,Nghia C. Truong,John S. Torday,Virender K. Rehan

Plasticizers May Activate Human Hepatic Peroxisome Proliferator-Activated Receptor Less Than That of a Mouse but May Activate Constitutive Androstane Receptor in Liver

Yuki Ito,Toshiki Nakamura,Yukie Yanagiba,Doni Hikmat Ramdhan,Nozomi Yamagishi,Hisao Naito,Michihiro Kamijima,Frank J. Gonzalez,Tamie Nakajima

PPARγ Expression and Function in Mycobacterial Infection: Roles in Lipid Metabolism, Immunity, and Bacterial Killing

Patricia E. Almeida,Alan Brito Carneiro,Adriana R. Silva,Patricia T. Bozza

Update on Ppar and Nonalcoholic Fatty Liver Disease

Gene P. Ables

Targeting PPARγ Signaling Cascade for the Prevention and Treatment of Prostate Cancer

Sakshi Sikka,Luxi Chen,Gautam Sethi,Alan Prem Kumar

Modulation of PPAR-γ by Nutraceutics as Complementary Treatment for Obesity-Related Disorders and Inflammatory Diseases

D. Ortu？o Sahagún,A. L. Márquez-Aguirre,S. Quintero-Fabián,R. I. López-Roa,A. E. Rojas-Mayorquín

The Role of PPAR in the Transcriptional Control by Agonists and Antagonists

Tamotsu Tsukahara

Time-Qualified Patterns of Variation of PPARγ, DNMT1, and DNMT3B Expression in Pancreatic Cancer Cell Lines

Valerio Pazienza,Francesca Tavano,Massimo Francavilla,Andrea Fontana,Fabio Pellegrini,Giorgia Benegiamo,Vincenzo Corbo,Fabio Francesco di Mola,Pierluigi Di Sebastiano,Angelo Andriulli,Gianluigi Mazzoccoli

Peroxisome Proliferator-Activated Receptor Agonists Differentially Regulate Inhibitor of DNA Binding Expression in Rodents and Human Cells

María del Carmen González,J. Christopher Corton,Nuria Acero,Dolores Mu？oz-Mingarro,Yolanda Quirós,Juan José álvarez-Millán,Emilio Herrera,Carlos Bocos

PPARγ as a Potential Target to Treat Airway Mucus Hypersecretion in Chronic Airway Inflammatory Diseases

Yongchun Shen,Lei Chen,Tao Wang,Fuqiang Wen

Modulation of Preactivation of PPAR-β on Memory and Learning Dysfunction and Inflammatory Response in the Hippocampus in Rats Exposed to Global Cerebral Ischemia/Reperfusion

Ge Kuang,Qin He,Yunmei Zhang,Ruichun Zhuang,Anling Xiang,Qingsong Jiang,Ying Luo,Junqing Yang

Peroxisome Proliferator-Activated Receptor Gamma and Regulations by the Ubiquitin-Proteasome System in Pancreatic Cancer

Athina Stravodimou,Gianluigi Mazzoccoli,Ioannis A. Voutsadakis

The Impact of PPAR Genetic Variants on IBD Susceptibility and IBD Disease Course

Jessica Mwinyi,Christa Grete-Wenger,Jyrki J. Eloranta,Gerd A. Kullak-Ublick

Altered Peroxisome-Proliferator Activated Receptors Expression in Human Endometrial Cancer

Pawe？ Knapp,Adrian Chabowski,Agnieszka B？achnio-Zabielska,Katarzyna Jarz？bek,S？awomir Wo？czyński

Global Gene Expression Profiling in PPAR-γ Agonist-Treated Kidneys in an Orthologous Rat Model of Human Autosomal Recessive Polycystic Kidney Disease

Daisuke Yoshihara,Masanori Kugita,Tamio Yamaguchi,Harold M. Aukema,Hiroki Kurahashi,Miwa Morita,Yoshiyuki Hiki,James P. Calvet,Darren P. Wallace,Takafumi Toyohara,Takaaki Abe,Shizuko Nagao

PPARs: Interference with Warburg’ Effect and Clinical Anticancer Trials

Joseph Vamecq,Jean-Marie Colet,Jean Jacques Vanden Eynde,Gilbert Briand,Nicole Porchet,Stéphane Rocchi

Idealized PPAR -Based Therapies: Lessons from Bench and Bedside

Angélica Amorim Amato,Francisco de Assis Rocha Neves

Effects of PPARγ Ligands on Leukemia

Yoko Tabe,Marina Konopleva,Michael Andreeff,Akimichi Ohsaka

Emerging PPARγ-Independent Role of PPARγ Ligands in Lung Diseases

Ajit A. Kulkarni,Collynn F. Woeller,Thomas H. Thatcher,Sesquile Ramon,Richard P. Phipps,Patricia J. Sime

PPARδ Activation Rescues Pancreatic β-Cell Line INS-1E from Palmitate-Induced Endoplasmic Reticulum Stress through Enhanced Fatty Acid Oxidation

Mingming Cao,Yuzhen Tong,Qingguo Lv,Xiang Chen,Yang Long,Li Jiang,Jun Wan,Yuwei Zhang,Fang Zhang,Nanwei Tong

The Effect of PPAR Agonists on the Migration of Mature and Immature Eosinophils

Steven G. Smith,Haruki Imaoka,Neha Punia,Anam Irshad,Luke L. Janssen,Roma Sehmi,Gail M. Gauvreau

Nutraceuticals as Ligands of PPAR

Meera Penumetcha,Nalini Santanam

Peroxisome Proliferator-Activated Receptor α Plays an Important Role in the Expression of Monocyte Chemoattractant Protein-1 and Neointimal Hyperplasia after Vascular Injury

Yu Peng,Qiang Li,Lu Zhang,Ming Bai,Zheng Zhang

The PPAR Gamma Agonist Troglitazone Regulates Erk 1/2 Phosphorylation via a PPARγ-Independent, MEK-Dependent Pathway in Human Prostate Cancer Cells

Adrienne Bolden,Lynikka Bernard,Danielle Jones,Tunde Akinyeke,LaMonica V. Stewart

Rosiglitazone Affects Nitric Oxide Synthases and Improves Renal Outcome in a Rat Model of Severe Ischemia/Reperfusion Injury

Boris Betz,Reinhard Schneider,Tobias Kress,Martin Alexander Schick,Christoph Wanner,Christoph Sauvant

Conditional Expression of Human PPARδ and a Dominant Negative Variant of hPPARδ In Vivo

Larry G. Higgins,Wojciech G. Garbacz,Mattias C. U. Gustafsson,Sitheswaran Nainamalai,Peter R. Ashby,C. Roland Wolf,Colin N. A. Palmer

PPAR and Oxidative Stress: Con( ) Catenating NRF2 and FOXO

Simone Polvani,Mirko Tarocchi,Andrea Galli

New Insights into the Role of Peroxisome Proliferator-Activated Receptors in Regulating the Inflammatory Response after Tissue Injury

Miriam D. Neher,Sebastian Weckbach,Markus S. Huber-Lang,Philip F. Stahel

Go




©2008-2020 OALib, Inc | Public user content licensed CC-BY 4.0 unless otherwise specified. OALib ISSN Online: 2333-9721 OALib ISSN Print: 2333-9705